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Abstract
Background: The recent identification of the cold-menthol sensory receptor (TRPM8; CMR1), provides us with
an opportunity to advance our understanding of its role in the pathophysiology of bladder dysfunction, and its
potential mediation of the bladder cooling reflex. In this study, we report the distribution of the cool and menthol
receptor TRPM8 in the urinary bladder in patients with overactive and painful bladder syndromes, and its
relationship with clinical symptoms.
Methods: Bladder specimens obtained from patients with painful bladder syndrome (PBS, n = 16), idiopathic
detrusor overactivity (IDO, n = 14), and asymptomatic microscopic hematuria (controls, n = 17), were
immunostained using specific antibodies to TRPM8; nerve fibre and urothelial immunostaining were analysed using
fibre counts and computerized image analysis respectively. The results of immunohistochemistry were compared
between the groups and correlated with the Pain, Frequency and Urgency scores.
Results: TRPM8-immunoreactive staining was observed in the urothelium and nerve fibres scattered in the
suburothelium. The nerve fibre staining was seen in fine-calibre axons and thick (myelinated) fibres. There was
marked increase of TRPM8-immunoreactive nerve fibres in IDO (P = 0.0249) and PBS (P < 0.0001) specimens,
compared with controls. A significantly higher number of TRPM8-immunoreactive axons were also seen in the
IDO (P = 0.0246) and PBS (P < 0.0001) groups. Urothelial TRPM8 and TRPM8-immunoreactive thick myelinated
fibres appeared unchanged in IDO and PBS. The relative density of TRPM8-immunoreactive nerve fibres
significantly correlated with the Frequency (r = 0.5487, P = 0.0004) and Pain (r = 0.6582, P < 0.0001) scores, but
not Urgency score.
Conclusion: This study demonstrates increased TRPM8 in nerve fibres of overactive and painful bladders, and
its relationship with clinical symptoms. TRPM8 may play a role in the symptomatology and pathophysiology of
these disorders, and may provide an additional target for future overactive and painful bladder pharmacotherapy.
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Despite considerable progress in understanding the
patho-physiology of bladder dysfunction, there is pres-
ently no consistently effective treatment for disorders like
the painful or overactive bladder syndromes. Painful
bladder syndrome (PBS) is a chronic bladder hypersensi-
tivity disorder that typically presents with suprapubic pain
related to bladder filling, accompanied by other symp-
toms such as increased frequency and nocturia, in the
absence of a definable aetiology [1]. The overactive blad-
der syndrome (OAB) is symptom complex characterized
by urinary urgency with or without urge incontinence,
usually with frequency and nocturia [2]. Detrusor overac-
tivity is often the underlying condition. Detrusor overac-
tivity should be further qualified as neurogenic detrusor
overactivity (NDO), when there is a relevant neurologic
condition or idiopathic detrusor overactivity (IDO), when
there is no defined cause [2]. The recent discovery of a
range of receptors in the bladder which respond to capsa-
icin, menthol, and temperature, and their expression in
subsets of sensory nerve fibres, provides an opportunity to
advance our understanding and treatment of these blad-
der disorders.
The mammalian sensory system is capable of detecting
and discriminating thermal stimuli over a broad tempera-
ture spectrum. Within this range, temperatures over 43°C
and below 15°C evoke not only a thermal sensation, but
also a feeling of pain [3]. Six thermosensitive ion channels
have been identified and cloned, all of which belong to
the transient receptor potential (TRP) superfamily of cat-
ion channels [3,4]. These thermo-TRP channels exhibit
distinct thermal activation thresholds [3,4], allowing us to
sense and differentiate a large spectrum of temperatures,
from below 0°C to 50°C. The physiological roles have yet
to be determined for most members of this family, though
their activation by specific chemical ligands and genetic
evidence has clearly implicated certain TRP channels in
the detection or transduction of a range of sensory stimuli
[5].
The existence of bladder receptors sensitive to cold has
been hypothesized since Bors and Blinn(1957) first
reported a human bladder cooling reflex [6]. Experiments
in cats showed that bladder thermosensation involves an
association of cold sensitive receptors associated with
unmyelinated C-fiber afferent neurons [7] and an intra-
vesical infusion of a menthol solution increased the
threshold temperature needed to trigger C-fibers, suggest-
ing that these responses were likely mediated by a receptor
sensitive to cold and menthol [8]. Subsequently, similar
sensitization was noted in humans suggesting that these
receptors also exist in the human bladder [9]. In 2002, a
major breakthrough in the study of cold thermosensation
was achieved, when two groups independently cloned
and characterized this nonselective cation channel sensi-
tive to cold temperatures and menthol, TRPM8 (also
known as CMR1) [10,11]. It belongs to the 'long', or mel-
astatin, subfamily of the transient receptor potential
(TRP) family of ion channels and is activated by menthol,
eucalyptol, icilin, and by temperatures below 25°C
[12,13].
TRPM8 was initially identified as a prostate-specific TRP
channel that was upregulated in malignant tissue [14].
Subsequent work detected TRPM8 in DRG and trigeminal
ganglia neurons, where it has been shown to be involved
in thermosensation [10,11]. Recently, TRPM8 has been
identified in a number of human genitourinary tract tis-
sues, including urinary bladder [15]. The reason for the
existence of the cool and menthol receptor TRPM8 in the
urinary tract is, however, still unknown. It has been pro-
posed that the cold receptors in the urinary tract may have
the same functional role as other thermoreceptors found
elsewhere in the body, that participate in the regulation
and maintenance of a stable central core temperature
[16,17]. This is supported by the fact that body cooling is
usually associated with an increased diuresis and thus the
bladder cooling reflex has presumably evolved to help
relieve the thermal ballast in the bladder when under
cooling stress [16]. In a recent study, TRPM8 has been sug-
gested to influence the cystometric parameters (micturi-
tion pressure and volume threshold for micturition) in
guinea pigs [18]. This may have an effect on the voiding
symptoms, such as frequency and urgency which are typi-
cal in bladder dysfunctions like the overactive and painful
bladder syndromes.
To further our understanding of role of TRPM8 in the
pathophysiology of bladder dysfunction, and discover
any relationship with clinical symptoms, we have studied




Bladder tissue specimens was obtained from 17 control
subjects under investigation for asymptomatic micro-
scopic haematuria, 14 subjects with idiopathic detrusor
overactivity and 16 subjects with painful bladder syn-
drome [19]. The mean (range) age of the controls was
51.1 years (21–89 years), IDO 52.2 years (32–73 years)
and PBS patients 46.7 years (22–67 years). Approval by
the local ethics committee (Reference No. – 00/5940
granted by Hammersmith, Queen Charlotte's and Chelsea
and Acton Hospitals REC) and informed consent were
obtained from patients and control subjects. Clinical
assessments of these subjects included history and clinical
examination, followed by midstream urine specimen
(MSU), culture and cytology and urodynamics (CMG).Page 2 of 11
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using the PUF Questionnaire [20]. In addition, the 'Pain
score' was also recorded on a Visual analogue scale (VAS)
on a scale of 0 to 10. All the controls had a 'pain score' of
0 (No Pain). In PBS patients, the 'pain score' ranged
between 1 (mild pain) to 3 (severe pain) on the PUF scale
and 3 to 8 on the visual analogue scale. The mean 'pain
score' of PBS group was 2.5(PUF) and 5.9(VAS). The 'Fre-
quency score' was obtained from PUF questionnaire and
was rated as 0 (3 – 6 voids per day), 1 (7 – 10), 2 (11 –
14), 3 (15 – 19) and 4 (20 +). Similarly, 'Urgency score'
obtained from PUF questionnaire and was graded as 0
(No urgency), 1 (Mild), 2 (Moderate) and 3 (Severe). All
of the PBS patients complained of frequency (>5 in 12 h),
nocturia (>2), urgency and suprapubic /pelvic pain with-
out any signs of detrusor overactivity on urodynamics.
The IDO patients presented with overactive bladder symp-
toms – urgency, with or without urge incontinence, fre-
quency and nocturia and showed involuntary detrusor
contractions during the filling phase of urodynamics [2].
Flexible or rigid cystoscopic bladder biopsies were
obtained from a consistent site, just above and lateral to
the ureteric orifices. A urine specimen was sent for culture
before each cystoscopy. All patients had sterile urine cul-
tures at the time of cystoscopy and biopsy.
Human tooth pulp specimens were immunostained using
the same staining protocol as the bladder specimens.
Preparation and staining of specimens
The samples were examined by histology (haematoxylin-
eosin staining) and immunohistochemistry.
Histology: Haematoxylin-eosin
Each specimen was immediately fixed in freshly prepared
4% paraformaldehyde w/v (PFA) in phosphate buffered
saline for 60 minutes and then transferred to 0.45 M
sucrose in phosphate buffered saline and refrigerated
overnight. The samples were embedded in OCT medium
and 10 µM sections were cut using a cryostat and stained
with haematoxylin and eosin. The sections were studied
for inflammatory changes, site of inflammation, vascular-
ity and urothelial changes (hyperplasia and dysplasia).
Antibodies
TRPM8: Affinity-purified rabbit antibody (GlaxoSmithK-
line, D SEL -2, Rabbit 1323) against cysteine tagged
TRPM8 N-terminal peptide CEKWNYKKHTKEFPT-
DAFGD, corresponding to amino acids sequences 85–105
was used at a dilution of 1:1500. For specificity of TRPM8-
immunostaining, the antibody was pre-incubated for 2
hours with decreasing concentration of peptide to TRPM8
before incubating with the tissue section.
Immunohistochemistry
Frozen specimens were embedded in OCT medium and
30 µm frozen sections collected onto PLL (Poly-L-lysine;
Sigma-Aldrich, Dorset, U.K.) coated slides. Sections were
fixed in freshly prepared 4% w/v paraformaldehyde in
phosphate-buffered saline (0.1 M phosphate; 0.9% w/v
saline; pH 7.3). Endogenous peroxidase was blocked by
incubation with 0.3% w/v hydrogen peroxide in metha-
nol. After a wash in phosphate-buffered saline, the tissue
sections were incubated with primary antibodies in dilu-
tions mentioned above. Methodological controls
included omission of primary antibodies, or their replace-
ment with non-immune serum. Sites of antibody attach-
ment were revealed using the nickel enhanced ABC
(peroxidase) method [21]. Nuclei were counterstained
with 0.1% w/v aqueous neutral red.
Image analysis
TRPM8-immunoreactive nerve fibres were counted using
a grid, as they were relatively fine and sparse. Grid fields
were arranged to cover the whole tissue section, and the
mean of two "blinded" observers, expressed as fibres per
unit grid area (0.5 mm2), was used for analysis. Compu-
terised image analysis using 'analySIS (version 5.0)' soft-
ware was performed to semi-quantify urothelial staining.
Images were captured via video link to an Olympus BX50
microscope (×40 objective) and scanned by the computer.
Positive immunostaining was obtained after setting the
grey level detection limits to threshold, and the area of
highlighted fibres obtained as % area of the field scanned.
Five fields per tissue section, chosen at random from a
grid, were scanned and the mean value was used for anal-
ysis.
Statistical analysis
Data was analysed between the groups by Mann Whitney
U test using GraphPad Prism software, P < 0.05 indicated
significance. The immunohistochemistry results were cor-
related with 'Pain, Frequency and Urgency scores' and
analysed using Spearman's Correlation 'r'.
Results
Histopathology
Urothelium was present in all specimens. Histology was
reported as normal in all controls, IDO and five PBS biop-
sies. The remaining eleven PBS bladder biopsies showed
non-specific chronic inflammation with dispersed mast
cells.
Immunohistochemistry
TRPM8-immunoreactive staining was observed in the
urothelium and nerve fibres scattered in the suburothe-
lium (Fig 1a). The TRPM8 antibody immunostained fine-
calibre axons (presumably unmyelinated C-fibres) and
both axonal and myelin staining of myelinated fibresPage 3 of 11
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TRPM8 immunoreactivity in human urinary bladder and dental pulpFigure 1
TRPM8 immunoreactivity in human urinary bladder and dental pulp. TRPM8 urothelial staining and suburothelial 
fibres (arrowed) in urinary bladder (a), Scale bar = 100 µm. TRPM8-immunoreactive axon (A)(b) and myelin (M)(b-c) staining in 
suburothelium, Scale bar = 50 µm. Similar, TRPM8-immunoreactive axon (A) and myelin (M) staining in dental pulp (d), Scale 
bar = 100 µm. TRPM8-immunoreactive nerve fibres in suburothelium (e) are abolished after pre-incubation with excess pep-
tide with TRPM8 antibody at a dilution of 1:1500 (f), Scale bar = 100 µm. Nuclei counterstained with neutral red.
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TRPM8-immunoreactive staining of nerve fibres in suburotheliumFigure 2
TRPM8-immunoreactive staining of nerve fibres in suburothelium. TRPM8-immunoreactive staining of nerve fibres in 
suburothelium of control (a-b), IDO (c-d) and PBS (e-f) bladders. Nuclei counterstained with neutral red. Scale bar = 100 µm.
BMC Urology 2006, 6:6 http://www.biomedcentral.com/1471-2490/6/6(presumably A-delta fibres) (Fig 1b–c). A similar pattern
of TRPM8 staining of fine axons and myelin was also seen
in human tooth pulp (Fig 1d), using two different TRPM8
antibodies (the current GSK1323/SEL-2 and a commer-
cially available antibody to TRPM8, H050-50 Phoenix
Pharmac, USA), and the same staining protocol. Pre-incu-
bation of the TRPM8 antibody with an excess of peptide
to TRPM8 completely abolished the urothelial and nerve
fibre TRPM8-immunoreactivity (Fig 1e–f). The immunos-
taining gradually reappeared with decreasing concentra-
tion of the peptide, supporting the specificity of the
TRPM8-immunostaining.
TRPM8-immunoreactive nerve fibres were seen scattered
throughout the suburothelium of the control (Fig 2a–b),
IDO (Fig 2c–d) and PBS (Fig 2e–f) bladder specimens.
Compared with control, the IDO (P = 0.0249) and PBS (P
< 0.0001) bladder specimens had a significantly larger
number of fibres immunoreactive to TRPM8 (Fig 3a). On
separately analysing the TRPM8-immunoreactive fine-cal-
ibre axons, a significant increase, similar to total nerve
fibres was seen in the IDO (P = 0.0246) and PBS (P <
0.0001) groups (Fig 3c). Compared to controls, a three-
and five-fold increase of TRPM8-immunoreactive axons
was seen in IDO and PBS groups respectively. The myelin
Image analysis of TRPM8 immunostaining in control and bladder disordersFigure 3
Image analysis of TRPM8 immunostaining in control and bladder disorders. Bar charts showing the relative numbers 
of TRPM8-immunoreactive total nerve fibres(a), axons(c) and myelinated fibres(d) per unit grid area (Mean ± SEM) and relative 
% area (Mean ± SEM) of TRPM8 urothelial immunoreactivity(b) in control (n = 17), IDO (n = 14) and painful bladder syn-
drome(n = 16) groups.Page 6 of 11
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and IDO groups, but this was not statistically significant
(PBS, P = 0.143, IDO, P = 0.076; Fig 3d).
There was no statistically significant difference in the
TRPM8 urothelial immunostaining between controls and
IDO (P = 0.1555) or PBS (P = 0.1816) groups (Fig 3b).
Correlation of TRPM8-immunoreactive nerve fibres with clinical scoresFigure 4
Correlation of TRPM8-immunoreactive nerve fibres with clinical scores. Scatter charts showing the correlation of 
TRPM8-immunoreactive total nerve fibres with (a) Pain Score (VAS; r = 0.6582, P < 0.0001); (b) Pain Score (PUF; r = 0.6165, P 
< 0.0001); (c) Urgency Score (r = 0.2997, P = 0.0715) and (d) Frequency Score (r = 0.5487, P = 0.0004) in all bladder specimen 
groups (n = 37).Page 7 of 11
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Correlation of TRPM8-immunoreactive axons and myelin fibres with clinical scoresFigure 5
Correlation of TRPM8-immunoreactive axons and myelin fibres with clinical scores. Scatter charts showing the 
correlation of TRPM8-immunoreactive axon fibres with (a) Pain (VAS; r = 0.6783, P < 0.0001); (b) Urgency (r = 0.3102, P = 
0.0617); (c) Frequency Scores (r = 0.5057, P = 0.0014) and the correlation of TRPM8-immunoreactive myelin fibres with (d) 
Pain (VAS; r = 0.2321, P = 0.1866); (e) Urgency (r = 0.09731, P = 0.5667); (f) Frequency (r = 0.2179, P = 0.1951) scores in all 
bladder specimen groups (n = 37).
BMC Urology 2006, 6:6 http://www.biomedcentral.com/1471-2490/6/6Correlation with clinical scores
The relative density of TRPM8-immunoreactive nerve
fibres significantly correlated with the Pain Score (VAS) (r
= 0.6582, P < 0.0001; Fig 4a). Similar correlation was seen
with 'Pain scores' measured via the PUF scale (r = 0.6165,
P < 0.0001) (Fig 4b). No correlation was found, however,
between TRPM8 urothelial immunoreactivity and Pain
score (VAS, r = 0.0713, P = 0.6978, PUF, r = 0.05448, P =
0.7596; Fig not shown).
No correlation was found between the 'Urgency score' and
the TRPM8-immunoreactive nerve fibre count (r =
0.2997, P = 0.0715; Fig 4c) or TRPM8 urothelial immuno-
reactivity (r = 0.1661, P = 0.3478; Fig not shown). The
'Frequency score' significantly correlated with the TRPM8-
immunoreactive nerve fibre count (r = 0.5487, P = 0.0004;
Fig 4d), but not with TRPM8 urothelial immunoreactivity
(r = 0.0438, P = 0.8053; Fig not shown).
Similar results were seen when the TRPM8-immunoreac-
tive axons were correlated with Pain (VAS, r = 0.6783, P <
0.0001, PUF, r = 0.6258, P < 0.0001), Urgency (r = 0.3102,
P = 0.0617) and Frequency (r = 0.5057, P = 0.0014) scores
(Fig 5a–c). However, the correlations with TRPM8-immu-
noreactive myelinated fibres were not significant for any
these scores (Pain, VAS, r = 0.2321, P = 0.1866, PUF, r =
0.2119, P = 0.2080; Urgency, r = 0.09731, P = 0.5667; Fre-
quency, r = 0.2179, P = 0.1951) (Fig 5d–f), which might
be due to the relative paucity of these myelinated fibres in
the specimens.
Discussion
In this study, we have demonstrated the cellular locations
of cool and menthol receptor TRPM8 in the human uri-
nary bladder. The presence of TRPM8 in the bladder has
been reported in previous studies [15]. Stein et al recently
demonstrated the presence of TRPM8-mRNA in the
human urinary bladder using RT-PCR, and by immun-
ofluorescence, TRPM8 in rat bladder and human urothe-
lial cells in culture [15]. While they showed that TRPM8
was localized within the bladder urothelial layer, in our
study TRPM8 immunoreactive fibres were seen scattered
in the suburothelium and nerve bundles, in addition to
urothelial staining. The different findings in these studies
may reflect the affinity and/or avidity of the antibodies,
and the methods used. Lindstrom and Mazieres [8], and
Geirsson et. al [9] performed studies suggesting the pres-
ence of cold and menthol sensitive receptors associated
with unmyelinated C-fibres in the cat and human blad-
ders. TRPM8 has been shown to be predominantly
expressed in small-diameter neurons in sacral DRG in
guinea pig, while the staining in large diameter cells was
diffuse or absent [18]. Abe and colleagues [22] have
reported the distribution of TRPM8 in the trigeminal gan-
glion. They observed TRPM8 immunoreactivity in a sub-
set of neurons with diameter of cell bodies in the range of
22.1 ± 4 µm that can be classified as small neurons (origin
of C or A delta fibres). They further characterized the
TRPM8-positive neurons by double staining analysis with
anti-NF200, a marker of A delta fibres, and anti-TRPM8
antibodies. TRPM8-immunoreactivity was found in a sub-
set of both NF200-negative and -positive neurons, and it
was concluded that TRPM8 was expressed in cell bodies of
A delta and C fibres. In agreement with Abe et al, TRPM8
appeared to stain both axons (possibly unmyelinated, C
fibres) and myelin (possibly myelinated, A delta fibres) in
our study, with two different antibodies. A similar pattern
of TRPM8 staining of fine axons and myelin was also seen
in human tooth pulp. However, this differentiation of
myelinated and unmyelinated fibres needs to be con-
firmed by further studies with selective markers. This data
must be interpreted with caution, even though we have
established TRPM8 specificity with conventional methods
– we may have in these TRPM8 antibodies, at the very
least, a marker of both unmyelinated and myelinated
fibres.
In control bladders, the TRPM8 immunoreactive fibres
were fine and few in number. The TRPM8-immunoreac-
tive staining was also detected in nerve fibre bundles, but
was extremely scarce. In contrast, in IDO and PBS blad-
ders, TRPM8-immunoreactive fibres were seen in nerve
bundles along with fine fibres scattered in the suburothe-
lium. The presence of increased immunoreactivity in
nerve bundles may indicate increased levels of axonally
transported TRPM8 in IDO and PBS bladders.
In the present study, we show that TRPM8-immunoreac-
tive nerve fibres were significantly increased in painful
bladder syndrome, and correlated with pain score. While
the role of TRPM8 in cold signaling is well known, its role
in nociception is debatable. Menthol, when applied at
low concentrations to the skin or mouth, elicits a pleasant
cool sensation, while higher doses can cause burning, irri-
tation and pain through activation and sensitization of C-
fibers [23]. Identification of endogenous ligands for
TRPM8 would provide further clues as to the pathophysi-
ological functions of this channel.
A salient finding of the study was a five-fold increase of
TRPM8-immunoreactive axons (ummyelinated fibres) in
PBS as compared to controls. The micturition reflex is nor-
mally mediated by small myelinated A-delta afferents
which respond to bladder distension; the C-fibres are
inactive and are therefore termed "silent C-fibres" [24].
However, they may become hyperactive during inflamma-
tion, exhibiting spontaneous firing when the bladder is
empty, and increased firing during bladder distension
[24]. In chronic inflammatory bladder diseases (e.g. in
interstitial cystitis/PBS), hyperexcitability of C-fibre affer-Page 9 of 11
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urgency and bladder pain [25]. This hypothesis is sup-
ported in our study by the correlation of these fibres with
pain. While there was no significant difference in urothe-
lial TRPM8 immunostaining in PBS and IDO specimens
or its correlation with clinical scores, further studies using
different methods of quantification, turnover and func-
tion of urothelial TRPM8 receptors are necessary before it
is concluded that they do not play a role in the pathophys-
iology of IDO or PBS.
The regulators of TRPM8 expression in the bladder are not
known. In a previous study, we have demonstrated
increased expression of TRPV1 fibres in PBS [26]. TRPM8
does not appear to be co-expressed with TRPV1 [11,27].
However, in DRG cultures, which have Nerve Growth Fac-
tor(NGF)-rich conditions, capsaicin and menthol sensi-
tivity are observed functionally in many neurons [10,27].
It may be hypothesized that in PBS patients, the high NGF
levels [28,29] lead to a phenotypic change in sensory
fibres which normally express TRPV1 alone, but which
now also express TRPM8 [30], resulting in a similar
increase of both receptors. Alternatively, visceral (pelvic)
afferents may be polymodal, and normally express both
TRPV1 and TRPM8, with increases of both receptors in
pathological states [31]. This can be supported by the fact
that capsaicin prevents the cold response in guinea-pig
bladders pre-treated with menthol [18], suggesting that
TRPM8 might be expressed in the C-afferent neurons,
which also express TRPV1. Further studies are needed of
rodent and human bladder pelvic afferents that originate
in sacral DRG neurons to address these alternatives.
In a recent study, Tsukimi and colleagues [18] demon-
strated that intravesical menthol administration increased
the micturition pressure and decreased the volume thresh-
old for micturition. It has been proposed that menthol
decreases the threshold for C-fiber activation by enhanc-
ing spontaneous activity. Therefore, it is possible that
TRPM8 may play a role in the regulation of threshold for
initiating micturition reflex. This proposal is supported by
our finding of significant correlation of frequency score
with the TRPM8-immunoreactive nerve fibres. In addi-
tion, an increase in TRPM8-immunoreactive nerve fibres
in IDO and PBS, suggests that TRPM8 may contribute to
the increased frequency which is a prominent symptom in
these conditions. Further correlations with clinical stud-
ies, such as the ice water test (to elicit the bladder cooling
reflex in both PBS and detrusor overactivity) and more
accurate methods of clinical measurement, including
voiding diaries and urodynamic results, are in progress to
determine the functional consequences of the TRPM8
receptor increase.
Conclusion
This study shows a significant increase of TRPM8-immu-
noreactive nerve fibres in suburothelium from patients
with overactive and painful bladder syndrome. A signifi-
cant correlation was also seen between the relative density
of the TRPM8-immunoreactive nerve fibres with the pain
and urinary frequency. Based on these findings we pro-
pose that the role and therapeutic potential of TRPM8
deserves further study, and may provide an additional tar-
get for future overactive and painful bladder pharmaco-
therapy.
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